Armune BioScience, Inc. is a medical diagnostics company that develops and commercializes unique proprietary technology exclusively licensed from the University of Michigan for diagnostic and prognostic tests for prostate, lung and breast cancers. Armune was incorporated as a Delaware Corporation in 2008 with corporate headquarters in Kalamazoo, MI and a research and commercial laboratory in Ann Arbor, MI.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/08/16 | $5,000,000 | Series A |
Grand Angels Maverick Capital | undisclosed |
